By Ben Grosscup August 31st 2026.

Read or listen here

My dad took this image of my mom and me in June 2026, days before my mother received an early-stage dementia diagnosis, likely Alzheimer’s disease. I’ve always expected grief and devastation for families after this diagnosis. The drugs available in the U.S. don’t halt, let alone reverse, progression of this degenerative neurological illness.

But my research this summer into NeuralCIM — a Cuban drug commercialized earlier this year — has left me hopeful. I leave for Cuba on Sept. 15 and will return with a 48-week supply for my mom.